AIS Antares Pharma Inc.
- 0 P/E
- 16.84 P/S
- 10.32 P/B
- -0.03 EPS
- 552.60% Cash ROIC
- 3.13 Cash Ratio
- 0 / 0% Dividend
- 1.10M Avg. Vol.
- 104.27M Shares
- 344.1M Market Cap.
Antares Pharma, Inc., a pharmaceutical company, focuses on self-injection pharmaceutical products and technologies, and topical gel-based products. It offers injection devices, which include Medi-Jector Vision for insulin; Zomajet 2 Vision, Zomajet Vision X, Twin-Jector EZ II, and Tjet for human growth hormone; Vibex pressure assisted auto injector platform that enables a controlled pressure deliv...
4-traders (press release) - 16 hours ago
4-traders (press release) - May 9, 2013
GSPInsider - May 7, 2013
SBWire (press release) - May 8, 2013
Business Wire (press release) - May 8, 2013
Antares Pharma (ATRS) Announces Quarterly Results - Zolmax
SBWire (press release) - Apr 26, 2013
NASDAQ - May 16, 2013
NIS - May 14, 2013
NIS - May 4, 2013
Wall St. Cheat Sheet - May 8, 2013